Immunophenotyping as a guide for targeted therapySONNEVELD, Pieter; PIETERS, Rob.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 4, pp 629-644, issn 1521-6926, 16 p.Article

Changes in hypercoagulability by asparaginase : a randomized study between two asparaginasesAPPEL, Inge M; HOP, Wim C. J; PIETERS, Rob et al.Blood coagulation & fibrinolysis. 2006, Vol 17, Num 2, pp 139-146, issn 0957-5235, 8 p.Article

Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristineHARTMAN, Annelies; VAN DEN BOS, Cor; STIJNEN, Theo et al.Cancer. 2006, Vol 106, Num 6, pp 1395-1401, issn 0008-543X, 7 p.Article

Towards targeted therapy for infant acute lymphoblastic leukaemiaSTAM, Ronald W; DEN BOER, Monique L; PIETERS, Rob et al.British journal of haematology. 2006, Vol 132, Num 5, pp 539-551, issn 0007-1048, 13 p.Article

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemiaBUITENKAMP, Trudy D; MATHOT, Ron A. A; DE HAAS, Valerie et al.Haematologica (Roma). 2010, Vol 95, Num 7, pp 1106-1113, issn 0390-6078, 8 p.Article

Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemiaTE WINKEL, Mariel L; APPEL, Inge M; PIETERS, Rob et al.Haematologica (Roma). 2008, Vol 93, Num 10, pp 1570-1574, issn 0390-6078, 5 p.Article

The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosisVAN NOESEL, Max M; PIETERS, Rob; VOUTE, P. A et al.Cancer letters. 2003, Vol 197, Num 1-2, pp 165-172, issn 0304-3835, 8 p.Article

Biology and Treatment of Acute Lymphoblastic LeukemiaPIETERS, Rob; CARROLL, William L.Hematology/oncology clinics of North America. 2010, Vol 24, Num 1, issn 0889-8588, vii, 1-18 [19 p.]Article

Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemiaVAN VLIERBERGHE, Pieter; PIETERS, Rob; BERNA BEVERLOO, H et al.British journal of haematology. 2008, Vol 143, Num 2, pp 153-168, issn 0007-1048, 16 p.Article

Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemiaHULLEMAN, Esther; BROEKHUIS, Mathilde J. C; PIETERS, Rob et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1322-1324, issn 0390-6078, 3 p.Article

A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trialHANFF, Lidwien M; MATHOT, Ron A. A; SMEETS, Oscar et al.International journal of clinical pharmacology and therapeutics. 2014, Vol 52, Num 8, pp 653-662, issn 0946-1965, 10 p.Article

Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemiaVAN DEN BERK, Lieke C. J; VAN DER VEER, Arian; WILLEMSE, Marieke E et al.British journal of haematology. 2014, Vol 166, Num 2, pp 240-249, issn 0007-1048, 10 p.Article

Gonadal function recovery in very long-term male survivors of childhood cancerVAN DORP, Wendy; VAN DER GEEST, Ivana M. M; LAVEN, Joop S. E et al.European journal of cancer (1990). 2013, Vol 49, Num 6, pp 1280-1286, issn 0959-8049, 7 p.Article

Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LM02 rearrangementsHOMMINGA, Irene; VUERHARD, Maartje J; LANGERAK, Anton W et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 258-261, issn 0390-6078, 4 p.Article

L-Asparaginase Treatment in Acute Lymphoblastic Leukemia: A Focus on Erwinia AsparaginasePIETERS, Rob; HUNGER, Stephen P; BOOS, Joachim et al.Cancer. 2011, Vol 117, Num 2, pp 238-249, issn 0008-543X, 12 p.Article

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyCOENEN, Eva A; RAIMONDI, Susana C; FORESTIER, Erik et al.Blood. 2011, Vol 117, Num 26, pp 7102-7111, issn 0006-4971, 10 p.Article

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cellsHULLEMAN, Esther; KAZEMIER, Karin M; HOLLEMAN, Amy et al.Blood. 2009, Vol 113, Num 9, pp 2014-2021, issn 0006-4971, 8 p.Article

WT1 mutations in T-ALLTOSELLO, Valeria; MANSOUR, Marc R; REAL, Pedro et al.Blood. 2009, Vol 114, Num 5, pp 1038-1045, issn 0006-4971, 8 p.Article

L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemiaAPPEL, Inge M; HOP, Wim C. J; VAN KESSEL-BAKVIS, Carla et al.Thrombosis and haemostasis. 2008, Vol 100, Num 2, pp 330-337, issn 0340-6245, 8 p.Article

Alterations in epithelial and mesenchymal intestinal gene expression during doxorubicin-induced mucositis in miceDE KONING, Barbara A. E; LINDENBERGH -KORTLEVE, Dicky J; PIETERS, Rob et al.Digestive diseases and sciences. 2007, Vol 52, Num 8, pp 1814-1825, issn 0163-2116, 12 p.Article

Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysisDE BONT, Judith M; DEN BOER, Monique L; KROS, Johan M et al.Journal of neuropathology and experimental neurology. 2007, Vol 66, Num 6, pp 505-516, issn 0022-3069, 12 p.Article

Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. CommentaryCAMITTA, Bruce M; TISSING, Wim J. E; MEIJERINK, Jules P. P et al.Blood. 2006, Vol 108, Num 3, issn 0006-4971, 787-788,1045-1049 [7 p.]Article

Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemiaVAN DER VELDEN, Vincent H. J; HOOGEVEEN, Patricia G; PIETERS, Rob et al.British journal of haematology. 2006, Vol 133, Num 4, pp 382-388, issn 0007-1048, 7 p.Article

Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1)HOOIJBERG, Jan Hendrik; JANSEN, Gerrit; ASSARAF, Yehuda G et al.Biochemical pharmacology. 2004, Vol 67, Num 8, pp 1541-1548, issn 0006-2952, 8 p.Article

Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors Dcrl and DcR2 is associated with dense promoter hypermethylationVAN NOESEL, Max M; VAN BEZOUW, Saskia; SALOMONS, Gajja S et al.Cancer research (Baltimore). 2002, Vol 62, Num 7, pp 2157-2161, issn 0008-5472Article